TABLE III.
Comparison of demographics, baseline comorbidities, and preoperative anticoagulant use between patients who developed access site complications and those who did not.
| Access Site Complication N=72 (5%) |
No Access Site Complication N=1299 (95%) |
P | |
|---|---|---|---|
| No. (%) | No. (%) | ||
| Age | |||
| <65 years | 15 (21) | 470 (36) | |
| 65–74 years | 20 (28) | 348 (27) | 0.01 |
| ≥ 75 years | 37 (51) | 481 (37) | |
| Female | 36 (50) | 559 (43) | 0.27 |
| BMI | |||
| Underweight (BMI <18.5) | 26 (6) | 58 (5) | |
| Normal weight (BMI 18.5–24.9) | 29 (28) | 368 (31) | 0.77 |
| Overweight (BMI 25–29.5) | 17 (37) | 384 (32) | |
| Obese (BMI ≥30) | 39 (29) | 382 (32) | |
| HTN | 56 (78) | 1013 (79) | 0.88 |
| HPL | 37 (51) | 786 (61) | 0.11 |
| DM | 39 (34) | 787 (61) | 0.26 |
| CAD | 38 (53) | 580 (45) | 0.23 |
| Hx of MI | 15 (21) | 235 (18) | 0.64 |
| Afib | 13 (18) | 176 (14) | 0.30 |
| Hx TIA | 3 (4) | 50 (4) | 0.76 |
| Hx CVA | 7 (10) | 150 (12) | 0.71 |
| CRI | 8 (11) | 216 (17) | 0.25 |
| ESRD on HD | 6 (8) | 125 (10) | 0.84 |
| CHF | 25 (35) | 231 (18) | <.01 |
| COPD | 4 (6) | 136 (11) | 0.23 |
| Current smoker | 16 (23) | 231 (19) | 0.43 |
| Prior smoker | 24 (37) | 505 (44) | 0.31 |
| Preoperative Anticoagulants | |||
| Aspirin | 53 (77) | 816 (68) | 0.18 |
| Clopidogrel | 28 (41) | 445 (37) | 0.61 |
| Warfarin | 22 (31) | 184 (15) | <.01 |
Afib, atrial fibrillation; BMI, body mass index; CAD, coronary artery disease; CRI, chronic renal insufficiency; COPD, chronic obstructive pulmonary disorder; CVA, cerebrovascular accident; DM, diabetes mellitus; ESRD, end stage renal disease; HD, hemodialysis; HPL, hyperlipidemia; HTN, hypertension; Hx, history; MI, myocardial infarction; TIA, transient ischemic attack